Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression

OBJECTIVE: Lobaplatin shows antitumor activity against a wide range of tumors, including metastatic breast cancer (BCa). The overexpression of metadherin (MTDH) is associated with poor prognosis of BCa patients. This study was designed to investigate the effect of lobaplatin on MCF-7 cell proliferat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drug Des Devel Ther
Egile Nagusiak: Tian, Wuguo, Hao, Shuai, Gao, Bo, Jiang, Yan, Zhang, Xiaohua, Zhang, Shu, Guo, Lingji, Zhao, Jianjie, Zhang, Gang, Chen, Yi, Li, Zhirong, Luo, Donglin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6211578/
https://ncbi.nlm.nih.gov/pubmed/30464390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S163157
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak